Evidence map›Paper›PMID 10233955›Full record

ArticleJournal of virology1999

Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.

S K Ghosh, D V Faller

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S K GhoshCancer Research Center, Boston University School of Medicine, Boston, Massachusetts, USA.
D V Faller
Cancer Research Center · US

Funding

Vascular endothelial growth factor in angiogenesis of RAP60AR020613 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FELSON, DAVID TOBIN · 1986 to 2000
$1.6M
CONTROL OF CELL GROWTH BY ONCOGENESR01CA050459 · NCI · DANA-FARBER CANCER INSTITUTE · PI FALLER, DOUGLAS V · 1990 to 2000
$323k
NCI NIH HHS CA50459NIAMS NIH HHS P60AR20613
6 · The paper itself

Abstract

Leukemia and lymphoma induced by feline leukemia viruses (FeLVs) are the commonest forms of illness in domestic cats. These viruses do not contain oncogenes, and the source of their pathogenic activity is not clearly understood. Mechanisms involving proto-oncogene activation subsequent to proviral integration and/or development of recombinant viruses with enhanced replication properties are thought to play an important role in their disease pathogenesis. In addition, the long terminal repeat (LTR) regions of these viruses have been shown to be important determinants for pathogenicity and tissue specificity, by virtue of their ability to interact with various transcription factors. Previously, we have shown that, in the case of Moloney murine leukemia virus, the U3 region of the LTR independently induces transcriptional activation of specific cellular genes through an LTR-generated RNA transcript (S. Y. Choi and D. V. Faller, J. Biol. Chem. 269:19691-19694, 1994; S.-Y. Choi and D. V. Faller, J. Virol. 69:7054-7060, 1995). In this report, we show that the U3 region of exogenous FeLV LTRs can induce transcription from collagenase IV (matrix metalloproteinase 9) and monocyte chemotactic protein 1 (MCP-1) promoters up to 12-fold. We also show that AP-1 DNA-binding activity and transcriptional activity are strongly induced in cells expressing FeLV LTRs and that LTR-specific RNA transcripts are generated in those cells. Activation of mitogen-activated protein kinase kinases 1 and 2 (MEK1 and -2) by the LTR is an intermediate step in the FeLV LTR-mediated induction of AP-1 activity. These findings thus suggest that the LTRs of FeLVs can independently activate transcription of specific cellular genes. This LTR-mediated cellular gene transactivation may play an important role in tumorigenesis or preleukemic states and may be a generalizable activity of leukemia-inducing retroviruses.

Indexed as

Gene Expression Regulation, EnzymologicMitogen-Activated Protein Kinase KinasesTerminal Repeat Sequences3T3 CellsAnimalsCatsChemokine CCL2CollagenasesDNAGenes, MHC Class ILeukemia Virus, FelineMAP Kinase Kinase 1MAP Kinase Kinase 2MicePromoter Regions, GeneticProtein Serine-Threonine KinasesChemokine CCL2CollagenasesDNAMap2k1 protein, mouseMAP Kinase Kinase 1MAP Kinase Kinase 2Mitogen-Activated Protein Kinase KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRNA, MessengerTranscription Factor AP-1

Identifiers

PMID10233955
PMCPMC112537
OpenAlexW2096007389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.